Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Overexpression of TRPM7 is Associated with Poor Prognosis in Human Ovarian Carcinoma

  • Wang, Jing (Department of Obstetrics and Gynaecology, Xiangya Hospital, Central South University) ;
  • Xiao, Ling (Department of Histology and Embryology of School of Basic Medical Sciences, Central South University) ;
  • Luo, Chen-Hui (The Affiliated Cancer Hospital of Xianaya School of Medicine, Central South University) ;
  • Zhou, Hui (The Affiliated Cancer Hospital of Xianaya School of Medicine, Central South University) ;
  • Hu, Jun (The Affiliated Cancer Hospital of Xianaya School of Medicine, Central South University) ;
  • Tang, Yu-Xi (The Affiliated Cancer Hospital of Xianaya School of Medicine, Central South University) ;
  • Fang, Kai-Ning (The Affiliated Cancer Hospital of Xianaya School of Medicine, Central South University) ;
  • Zhang, Yi (Department of Obstetrics and Gynaecology, Xiangya Hospital, Central South University)
  • Published : 2014.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The melastatin-related transient receptor potential 7 channel (TRPM7) is a nonselective cation channel that has been shown to promote tumor metastasis and progression. In this study, we determined the expression of TRPM7 in ovarian carcinomas and investigated its possible prognostic value. Materials and Methods: Samples were collected from 138 patients with ovarian cancer. Expression of TRPM7 was assessed by real-time PCR and immunohistochemistry, expressed with reference to an established scoring system and related to clinical pathological factors. Kaplan-Meier survival analysis was applied to estimate disease-free survival (DFS) and overall survival (OS). Univariate and multivariate cox regression analyses were performed to correlate TRPM7 expression levels with DFS and OS. Results: TRPM7 was highly expressed in ovarian carcinoma and significantly associated with decreased disease-free survival (DFS: median 20 months vs. 42 months, P=0.0002) and overall survival (OS: median 27 months vs. 46 months, P<0.001). Conclusion: Overexpression of TRPM7 expression is significantly associated with poor prognosis in patients with ovarian cancer.

Keywords

References

  1. Bian J, Li B, Kou XJ, et al (2013). Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer. Asian Pac J Cancer Prev, 14, 6241-3. https://doi.org/10.7314/APJCP.2013.14.11.6241
  2. Clapham, DE. (2003). TRP channels as cellular sensors. Nature, 426, 517-24. https://doi.org/10.1038/nature02196
  3. Dhennin-Duthille I, Gautier M, Faouzi M, et al (2011). High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem, 28, 813-22. https://doi.org/10.1159/000335795
  4. Gao H, Chen X, Du X, et al (2011). EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium, 50, 559-68. https://doi.org/10.1016/j.ceca.2011.09.003
  5. Hanano T, Hara Y, Shi J, et al (2004). Involvement of TRPM7 in cell growth as a spontaneously activated $Ca^{2+}$ entry pathway in human retinoblastoma cells. J Pharmacol Sci, 95, 403-19. https://doi.org/10.1254/jphs.FP0040273
  6. He L, Peng K, Liu Y, et al (2013). Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. Onco Targets Ther, 6, 1539-43.
  7. Jiang J, Li MH, Inoue K, et al (2007). Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res, 67, 10929-38. https://doi.org/10.1158/0008-5472.CAN-07-1121
  8. Kim K, Zang R, Choi SC, et al (2009). Current status of gynecological cancer in China. J Gynecol Oncol, 20, 72-6. https://doi.org/10.3802/jgo.2009.20.2.72
  9. Ma SH, Kim BG, Choi JY, et al (2012). Korean epithelial ovarian cancer study (Ko-EVE): protocols and interim report. Asian Pac J Cancer Prev, 13, 3731-40. https://doi.org/10.7314/APJCP.2012.13.8.3731
  10. Middelbeek J, Kuipers AJ, Henneman L, et al (2012). TRPM7 is required for breast tumor cell metastasis. Cancer Res, 72, 4250-61. https://doi.org/10.1158/0008-5472.CAN-11-3863
  11. Minke B. (2006). TRP channels and $Ca^{2+}$ signaling. Cell Calcium, 40, 261-75. https://doi.org/10.1016/j.ceca.2006.05.002
  12. Nadler MJ, Hermosura MC, Inabe K, et al (2001). LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature, 411, 590-5. https://doi.org/10.1038/35079092
  13. Paravicini TM, Chubanov V, and Gudermann T. (2012). TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol, 44, 1381-4. https://doi.org/10.1016/j.biocel.2012.05.010
  14. Pham DL, Scheble V, Bareiss P, et al (2013). SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol, 32, 358-67. https://doi.org/10.1097/PGP.0b013e31826a642b
  15. Pitakkarnkul S, Tangjitgamol S, Srijaipracharoen, et al (2013). Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pac J Cancer Prev, 14, 2421-7. https://doi.org/10.7314/APJCP.2013.14.4.2421
  16. Prevarskaya N, Zhang L, and Barritt G. (2007). TRP channels in cancer. Biochim Biophys Acta, 1772, 937-46. https://doi.org/10.1016/j.bbadis.2007.05.006
  17. Qiu JJ, Guo JJ, Lv TJ, et al (2013). Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer. Tumour Biol, 34, 2971-5. https://doi.org/10.1007/s13277-013-0860-6
  18. Ramsey IS, Delling M, and Clapham DE. (2006). An introduction to TRP channels. Annu Rev Physiol, 68, 619-47. https://doi.org/10.1146/annurev.physiol.68.040204.100431
  19. Rybarczyk P, Gautier M, Hague F, et al (2012). Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int J Cancer, 131, E851-61. https://doi.org/10.1002/ijc.27487
  20. Siegel R, Naishadham D, and Jemal A. (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  21. Thigpen T, duBois A, McAlpine J, et al (2011). First-line therapy in ovarian cancer trials. Int J Gynecol Cancer, 21, 756-62. https://doi.org/10.1097/IGC.0b013e31821ce75d
  22. Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25. https://doi.org/10.1038/nrc3144
  23. Wang B, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in china. Asian Pac J Cancer Prev, 15, 191-3. https://doi.org/10.7314/APJCP.2014.15.1.191
  24. Yee NS, Chan AS, Yee JD, and Yee RK. (2012a). TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: potential roles as cancer biomarkers and targets. Scientifica, 2012, 415158.
  25. Yee NS, Zhou W, Lee M, and Yee RK. (2012b). Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. Cancer Lett, 318, 99-105. https://doi.org/10.1016/j.canlet.2011.12.007

Cited by

  1. IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5767
  2. Suppression of TRPM7 Inhibits Proliferation, Migration, and Invasion of Malignant Human Glioma Cells vol.21, pp.3, 2014, https://doi.org/10.1111/cns.12354
  3. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis vol.37, pp.7, 2016, https://doi.org/10.1007/s13277-015-4636-z
  4. Role of TRP ion channels in cancer and tumorigenesis vol.38, pp.3, 2016, https://doi.org/10.1007/s00281-015-0525-1
  5. Mibefradil represents a new class of benzimidazole TRPM7 channel agonists vol.468, pp.4, 2016, https://doi.org/10.1007/s00424-015-1772-7
  6. Xyloketal B Suppresses Glioblastoma Cell Proliferation and Migration in Vitro through Inhibiting TRPM7-Regulated PI3K/Akt and MEK/ERK Signaling Pathways vol.13, pp.4, 2015, https://doi.org/10.3390/md13042505
  7. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth vol.38, pp.4, 2017, https://doi.org/10.3892/or.2017.5883
  8. TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling vol.38, pp.1, 2019, https://doi.org/10.1186/s13046-019-1061-y